Eli Lilly & Co. (NYSE: LLY) reported Q2 EPS of $1.50, $0.20 better than the analyst estimate of $1.30. Revenue for the quarter came in at $6.36 billion versus the consensus estimate of $6.05 billion.

GUIDANCE:

Eli Lilly & Co. sees FY2018 EPS of $5.40-$5.50, versus the consensus of $5.15.

For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.